Glenmark Pharmaceuticals Revenue and Competitors

Mahwah, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Glenmark Pharmaceuticals's estimated annual revenue is currently $3.3B per year.(i)
  • Glenmark Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Glenmark Pharmaceuticals has 16515 Employees.(i)
  • Glenmark Pharmaceuticals grew their employee count by 13% last year.

Glenmark Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Sr. VP Global Clinical OperationsReveal Email/Phone
3
Secretary to Sr. VP CQAReveal Email/Phone
4
Sr VP - R&DReveal Email/Phone
5
Sr. VP & CFO - Global Formulations BusinessReveal Email/Phone
6
Interim Chief Compliance Officer, North AmericaReveal Email/Phone
7
Supply Planner External Manufacturing (CMO/PPIC)Reveal Email/Phone
8
Sr. VP & Global Head, Medical AffairsReveal Email/Phone
9
VPReveal Email/Phone
10
Group VP & Global Head - Integrated Supply Chain (Demand & Supply) & LogisticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Glenmark Pharmaceuticals?

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). We have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

keywords:N/A

N/A

Total Funding

16515

Number of Employees

$3.3B

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Glenmark Pharmaceuticals News

2022-04-20 - Glenmark Pharma bags 'India Pharma Innovation of the Year' Award from Indian Govt

Glenmark won the 'Indian Pharma Innovation of the Year' award for the second year in a row. April 28, 2022 11:15 IST | India Infoline News Service.

2022-04-19 - Glenmark receives the 'India Pharma Innovation of the Year ...

MUMBAI, India, April 27, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company,...

2022-04-17 - Glenmark becomes the First Pharmaceutical Company to ...

Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7842.5M56018N/AN/A